Declan J Connoley

A Nonrandomized Pilot Study to Investigate the Acceptability and Feasibility of LivR Well: A Multifaceted 28-Day Home-Based Liver Optimization Program for Acute-on-Chronic Liver Failure

Natalie L. Y. Ngu, Edward Saxby, Thomas Worland, Patricia S. Anderson et autres

Background and Aims Acute-on-chronic liver failure (ACLF) has a 22%–74% 28-day mortality rate and 30%–40% 30-day readmission rate. We investigated the acceptability and feasibility of a multimodal community intervention for ACLF. Methods A single-arm nonrandomized pilot study of consecutive participants with ACLF …

au (code pays fourni par la source)

Gastric intestinal metaplasia: Prevalence in a large Australian center and nationwide survey of endoscopic practice

Imogen Hartley, Declan J Connoley, Nikhita Sane, Ryan D. Hirsch et autres

Abstract Background and Aim Atrophic gastritis (AG) and gastric intestinal metaplasia (GIM) are early changes in the stepwise progression to gastric adenocarcinoma. There is heterogeneity in international guidelines regarding the endoscopic diagnosis and surveillance of AG and GIM. This study aims to …

au (code pays fourni par la source)

Assessing quality of magnetic resonance enterography and its impact on disease assessment of ileal Crohn’s disease

Anuj Bohra, Declan J Connoley, Danny Con, Jonathan Philip Segal et autres

BACKGROUND/AIMS: Assessment of quality of magnetic resonance enterography (MRE) in small bowel Crohn's disease (CD) activity evaluation has received little attention. We assessed the impact of bowel distention and motion artifact on MRE activity indices in ileal CD. METHODS: A cohort of …

au (code pays fourni par la source)

Examining the role of thiopurine metabolite testing in the management of patients with autoimmune hepatitis

Andrew Roberts, Declan J Connoley, Ryan D. Hirsch, Gauri Mishra et autres

au (code pays fourni par la source)

The prevalence and prognostic significance of vitamin C deficiency in patients with cirrhosis: a prospective observational cohort study

Declan J Connoley, Phil Ha, Joseph Nim, Elaine Koh et autres

cn (code pays fourni par la source)

GASTRIC INTESTINAL METAPLASIA: AN AUSTRALIAN CENTER’S EXPERIENCE

Imogen Hartley, Declan J Connoley, Nikhita Sane, Ryan D. Hirsch et autres

Long-Term Outcomes in Patients on Life-Long Antibiotics: A Five-Year Cohort Study

Christopher R. Kiss, Declan J Connoley, Kathryn Connelly, Kylie Horne et autres

Background: Little is known about the impacts at an individual level of long-term antibiotic consumption. We explored health outcomes of long-term antibiotic therapy prescribed to a cohort of patients to suppress infections deemed incurable. Methods: We conducted a 5-year longitudinal study of …

au (code pays fourni par la source)

The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study

Declan J Connoley, Preya Janubhai Patel, Brian Hogan, Sudeep Tanwar et autres

BACKGROUND: Alcohol is the main cause of chronic liver disease. The Enhanced Liver Fibrosis (ELF) test is a serological biomarker for fibrosis staging in chronic liver disease, however its utility in alcohol-related liver disease warrants further validation. We assessed the diagnostic and …

gb, au (code pays fourni par la source)

ID: 3526077 NO REDUCTION IN ENDOSCOPIC CANCER DETECTION DESPITE A REDUCTION IN CASE VOLUME DUE TO THE COVID-19 PANDEMIC: RESULTS FROM A TERTIARY ACADEMIC CENTRE

Daniel A. Schneider, Timothy S. Phan, Kathryn Goss, Declan J Connoley et autres

P210 Enhanced-liver-fibrosis score was not influenced by alcohol consumption in a patient cohort with alcohol-use-disorders

Freya Rhodes, Sara Cococcia, Declan J Connoley, Preya Janubhai Patel et autres

Introduction Although only 20% of people with Alcohol Use Disorder (AUD) develop liver fibrosis/cirrhosis, those affected experience high morbidity and mortality. Better strategies are required to identify cases of advanced liver fibrosis amongst people with AUD. The Enhanced Liver Fibrosis (ELF) test …

gb, au (code pays fourni par la source)

P211 Alcohol use disorders and liver fibrosis – cases are missed through failure to test

Freya Rhodes, Sara Cococcia, Declan J Connoley, Preya Janubhai Patel et autres

Background and Aims Alcohol Use Disorders (AUD) account for 7.2% hospital admissions per year in the UK. While a proportion of these people are recognised to have liver disease and are managed by liver specialists, many are managed by a wide range …

gb, au (code pays fourni par la source)

The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: A cohort study.

Declan J Connoley, Preya Janubhai Patel, Brian Hogan, Sudeep Tanwar et autres

Abstract Background Alcohol is the main cause of chronic liver disease. The Enhanced Liver Fibrosis (ELF) test is a serological biomarker for fibrosis staging in chronic liver disease, however its utility in alcohol-related liver disease warrants further validation. We assessed the diagnostic …

au, us, gb (code pays fourni par la source)